Chen-Yuan Lin

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

ADAM9 Promotes Lung Cancer Metastases to Brain by a Plasminogen Activator-Based Pathway

Chen-Yuan Lin, Hung‐Jen Chen, Cheng-Chung Huang et al. · Cancer Research · 2014 · 104 citations

Medicine, Cancer Biology, Oncology +15

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT

Chen-Yuan Lin, Chia-Fong Cho, Shih-Ting Bai et al. · Scientific Reports · 2017 · 57 citations · Full text

Medicine, Molecular Biology, Oncology +16

Neutrophil–to–lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Jhe‐Cyuan Guo, Chia‐Chi Lin, Chen-Yuan Lin et al. · Anticancer Research · 2019 · 51 citations · Full text

Medicine, Immunology, Oncology +10

The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan

Chin-Chan Lin, Hui-Wen Chang, Chen-Yuan Lin et al. · International Journal of Clinical Oncology · 2012 · 40 citations

Veterinary Medicine, Oncology, Surgery +12